Obesity Medication Category Review 

From headlines in the business pages to social media feeds, you can’t escape stories about weight loss drugs.  Which stars are using them, who is writing the prescriptions – label or off-label, how much they cost or product shortages – everyday there is a new story.  This raises questions and concerns from health plan sponsors, brokers and consultants and covered employees. We’d like to help sponsors and EBC’s feel more confident about this category of drugs and those that may be coming to market so that you can more effectively manage your programs.

Join us at 3PM CT, May 25 for a focused study session (virtual) to:

1. Understand obesity as a disease
2. Review the clinical and economic impact of obesity
3. Learn the clinical benefits of intentional weight loss
4. Overview the current anti-obesity medication (AOM) class

Presentation by: Derrick Grass, PharmD, CSP
Medical Account Associate Director, Managed Markets
Novo Nordisk

Free Registration

Contact Collier Case at ccase@machc.org for more information.